Erectile Dysfunction

The EAU 2026 erectile dysfunction pathway — a basic work-up of medical and psychosexual history with a validated questionnaire, focused examination and laboratory tests including early-morning total testosterone, Princeton IV cardiovascular risk stratification, select-case advanced testing, then the treatment ladder from first-line PDE5 inhibitors through intracavernosal injection and the less-invasive alternatives to a penile prosthesis, with follow-up and post-prostatectomy rehabilitation. Switch between the visual Pathway map and the phase-by-phase Explorer.